Stay updated on APG-2575 in MM: Monotherapy or Combo with Lenalidomide/DXMS Clinical Trial
Sign up to get notified when there's something new on the APG-2575 in MM: Monotherapy or Combo with Lenalidomide/DXMS Clinical Trial page.

Latest updates to the APG-2575 in MM: Monotherapy or Combo with Lenalidomide/DXMS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now includes an updated status indicating that the last known status was 'Recruiting' as verified by Ascentage Pharma Group Inc. in March 2023, while the previous mention of heavy traffic affecting NLM-NCBI services has been removed.SummaryDifference8%
- Check35 days agoNo Change Detected
- Check43 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check50 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference1.0%
- Check100 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to APG-2575 in MM: Monotherapy or Combo with Lenalidomide/DXMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APG-2575 in MM: Monotherapy or Combo with Lenalidomide/DXMS Clinical Trial page.